Another agency questioning Polyheme

Since my initial posting about the blood substitute, Polyheme, two hospitals have suspended their participation in the study of the Northfield Labs product and the federal Office of Human Research Protections has told the FDA that it has "urgent ethical concerns". Still the company claims that they are "on strong scientific, ethical and legal ground".